Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

healthcare value value-based care money dollar

HHS to release first wave of drugs up for price negotiations Sept. 1

HHS is moving forward with drug price negotiations afforded to CMS under the Inflation Reduction Act.

Thumbnail

Lawmaker pushes to eliminate OOP costs for supplemental breast imaging

HB 575 would remove financial barriers for women who are recommended to undergo supplemental breast imaging, such as an MRI, CT or ultrasound, when the exams are deemed medically necessary.

Thumbnail

'I'm not going to do it': Imaging leader tells staff to boycott unjustifiable exams on migrant children

The UK's Home Secretary recently proposed the use of X-ray, CT and/or MRI for age checks to determine which migrants are, in fact, children and which ones might be posing as children in an attempt to remain in the country.

FDA approves new Alzheimer’s disease drug

The U.S. Food and Drug Administration (FDA) approved a new drug treatment for Alzheimer’s disease, Leqembi (lecanemab).

Amazon

Amazon’s $4B acquisition of Medical One clears regulators in Oregon

Amazon has overcome another step toward acquiring primary care group One Medical for $3.9 billion after the Oregon Housing Authority cleared the deal.

Thumbnail

GE HealthCare stands on its own

GE has completed the spinoff of its healthcare business, and GE HealthCare began trading as its own entity on the Nasdaq Jan. 4.

Thumbnail

Industry group pushes for cannabis screenings in surgery

The American Society of Regional Anesthesia and Pain Medicine (ASRA Pain Medicine) has released new guidelines surrounding cannabis use in relation to surgery, advocating for all patients undergoing procedures with anesthesia to be screened for cannabis use.

 

Nuclear Regulatory Commission to reconsider extravasation reporting requirements

The NRC noted that advancements in nuclear medicine and increased use of radiopharmaceuticals prompted the commission to reconsider the exclusion of extravasation from medical event reporting.